“Psoas Hitch” procedure

U 51-godišnjega bolesnika učinjena je transuretralna resekcija urotelijalnoga karcinoma završnoga dijela lijevoga mokraćovoda. U sljedećoj fazi odstranjen je donji dio lijevoga mokraćovoda s pripadajućim dijelom mokraćnoga mjehura te je na toj strani postavljena perkutana nefrostoma. Radi postizanja boljega kapaciteta mokraćnoga mjehura, učinjena je transuretralna resekcija prostate i u posljednjoj fazi učinjen je ”psoas hitch” postupak s ureteroneocistostomijom.In 51-year-old patient urothelial carcinoma of the terminal left ureter was resected transurethrally. In the next phase, a distal part of the left ureter with a ”cuff” of the bladder was removed, and ipsilateral percutaneous nephrostomy introduced. Better bladder capacity was achieved by transurethral resection of the prostate, and in the last phase left-sided ”psoas hitch” procedure with ureteroneocystostomy was performe

Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: Long-term data

Over the last decade, a number of minimally invasive therapies have been investigated for the treatment of symptomatic benign prostatic hyperplasia. Most of these therapies use thermal energy to ablate prostatic tissue. The major common problem with all these new minimally invasive therapies has been the lack of long-term data concerning efficacy, re-intervention rates and side-effects. We present here the available long-term data on these alternative minimally invasive therapies for benign prostatic hyperplasia and their current place in the urologist's armamentarium. © 2002 Lippincott Williams & Wilkins.SCOPUS: re.jinfo:eu-repo/semantics/publishe